A pharmacy practice professor explains how GLP-1s may blunt reward signaling tied to drinking and why pancreatitis risk belongs in counseling.
Kimberly Barefield, PharmD, MHA
Advertisement
Articles by Kimberly Barefield, PharmD, MHA
Advertisement
Latest Updated Articles
Alcohol and GLP-1 Therapy: Key Counseling Points for PharmacistsSeptember 23rd 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Understanding Kratom: Pharmacology, Safety, and Regulation
3
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
4
Survodutide Shows Cardiovascular Safety in SYNCHRONIZE-CVOT
5